Almanack Investment Partners LLC. Sells 100,000 Shares of Evolv Technologies Holdings, Inc. (NASDAQ:EVLV)

Almanack Investment Partners LLC. decreased its position in Evolv Technologies Holdings, Inc. (NASDAQ:EVLV - Free Report) by 71.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 40,254 shares of the company's stock after selling 100,000 shares during the quarter. Almanack Investment Partners LLC.'s holdings in Evolv Technologies were worth $159,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its holdings in shares of Evolv Technologies by 8.5% during the third quarter. JPMorgan Chase & Co. now owns 60,441 shares of the company's stock valued at $245,000 after acquiring an additional 4,756 shares in the last quarter. MetLife Investment Management LLC increased its holdings in shares of Evolv Technologies by 7.1% during the third quarter. MetLife Investment Management LLC now owns 77,055 shares of the company's stock valued at $312,000 after acquiring an additional 5,090 shares in the last quarter. Sequoia Financial Advisors LLC increased its holdings in shares of Evolv Technologies by 50.5% during the third quarter. Sequoia Financial Advisors LLC now owns 15,190 shares of the company's stock valued at $62,000 after acquiring an additional 5,100 shares in the last quarter. Platform Technology Partners increased its holdings in shares of Evolv Technologies by 3.0% during the fourth quarter. Platform Technology Partners now owns 185,451 shares of the company's stock valued at $733,000 after acquiring an additional 5,431 shares in the last quarter. Finally, HighTower Advisors LLC increased its holdings in shares of Evolv Technologies by 3.1% during the third quarter. HighTower Advisors LLC now owns 202,680 shares of the company's stock valued at $820,000 after acquiring an additional 6,183 shares in the last quarter. Institutional investors own 66.65% of the company's stock.

Evolv Technologies Stock Performance

NASDAQ:EVLV remained flat at $3.92 on Wednesday. The company's stock had a trading volume of 712,377 shares, compared to its average volume of 1,586,799. The stock has a market cap of $617.60 million, a PE ratio of -28.00 and a beta of 1.66. The business has a 50-day moving average price of $3.79 and a 200-day moving average price of $3.62. Evolv Technologies Holdings, Inc. has a fifty-two week low of $2.01 and a fifty-two week high of $5.73.

Analysts Set New Price Targets

Several research firms recently commented on EVLV. Lake Street Capital dropped their price objective on Evolv Technologies from $3.50 to $2.75 and set a "hold" rating on the stock in a research report on Monday, October 28th. Northland Securities cut Evolv Technologies from an "outperform" rating to a "market perform" rating in a research report on Monday, October 28th. Northland Capmk cut Evolv Technologies from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 28th. Finally, TD Cowen cut Evolv Technologies from a "strong-buy" rating to a "strong sell" rating in a research report on Monday, October 28th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Evolv Technologies has a consensus rating of "Hold" and a consensus price target of $5.60.

About Evolv Technologies

Evolv Technologies Holdings, Inc provides artificial intelligence (AI)-based weapons detection for security screening in the United States and internationally. Its products include Evolv Express, a touchless security screening system designed to detect firearms, improvised explosive devices, and tactical knives; and Evolv Insights that provides self-serve access, insights regarding visitor flow and arrival curves, location specific performance, system detection performance, and alarm statistics.